Compounded BHRT vs FDA-Approved HRT
Twenty years ago, one study scared a generation of women off hormones — and we're still paying for it. But here's what almost nobody explains: not all hormones are the same, and "bioidentical" doesn't mean what most people think. In this episode, Jessica Christy untangles two questions people constantly blur together: bioidentical vs. synthetic (the molecule), and FDA-approved vs. custom-compounded (the source). They're not the same question — and knowing the difference changes the conversation you have with your provider. She walks through the WHI backstory fairly (what that 2002 study actually used, and why its findings got over-generalized to all hormone therapy), what the clot-risk data really shows by molecule and by route, and where custom-compounded hormones do — and don't — fit, according to ACOG and the Endocrine Society. In this episode: Why "bioidentical" does NOT mean "compounded" — and why many bioidentical hormones are FDA-approved The real story behind the 2002 WHI study and the harm of over-generalizing it Molecule matters: estradiol and micronized progesterone vs. older CEE/MPA Route matters: why oral vs. transdermal changes the risk picture Where custom-compounded hormones, pellets, and saliva testing actually fit The smart questions to ask your provider before starting hormone therapy The goal isn't a miracle — it's the right molecule, the right route, the right dose, monitored over time. If you've been scared off hormones, or told "you're too old," the real answer depends on your molecule, route, dose, and risk factors. Book a Cultured Wellness hormone evaluation to see if — and which — hormone therapy fits you. BOOK NOW This episode is education, not medical advice — always loop in your own provider. Because at Culture Collective, we inspire confidence.
